About
Kenneth Getz is a Research Professor in the Department of Public Health and Community Medicine at Tufts University School of Medicine, based at 75 Kneeland Street in Boston, MA. He holds an MBA from Northwestern University (1991) and a BA from Brandeis University (1984). With over two decades of pioneering research, he is internationally recognized for quantifying trends in drug development efficiency, clinical trial performance, and global investigative site operations.
His research examines:
- Phase I-IV protocol design strategies impacting development economics
- Clinical research operations including patient recruitment, data management, and outsourcing models
- Global contract research organization markets and site management practices
- Regulatory reforms and multi-stakeholder collaboration frameworks
His 193+ publications predominantly focus on clinical trial optimization, with recent trends showing concentrated work in risk-based quality management, protocol amendment impact assessments, decentralized trial methodologies, and diversity/inclusion strategies. Analysis reveals recurring themes of operational efficiency metrics, regulatory compliance frameworks, and economic value quantification across therapeutic areas.
He has secured 63 research grants from organizations including the National Institutes of Health, Drug Information Association, and various pharmaceutical sponsors. Funded projects address clinical trial efficiency, protocol data relevance, patient engagement capabilities, and decentralized trial valuation.
No information about research labs, student advising, or scientific awards was found in the provided materials.
